Connection

George Arana to Humans

Back to Details
This is a "connection" page, showing publications George Arana has written about Humans.
George Arana
Connection Strength
0.236
Humans
  1. Documented combat exposure of US veterans seeking treatment for combat-related post-traumatic stress disorder. Br J Psychiatry. 2005 Jun; 186:467-72; discussion 473-5.
    View in: PubMed
    Score: 0.010
  2. Prevalence of posttraumatic stress disorder in Veterans Affairs primary care clinics. Gen Hosp Psychiatry. 2005 May-Jun; 27(3):169-79.
    View in: PubMed
    Score: 0.010
  3. Remote psychotherapy for terminally ill cancer patients. J Telemed Telecare. 2005; 11(3):157-9.
    View in: PubMed
    Score: 0.009
  4. Service use and satisfaction among elderly former prisoners of war in South Carolina. Mil Med. 2003 Aug; 168(8):682-7.
    View in: PubMed
    Score: 0.009
  5. Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms. Int Clin Psychopharmacol. 2003 Jan; 18(1):1-8.
    View in: PubMed
    Score: 0.008
  6. Disability compensation seeking among veterans evaluated for posttraumatic stress disorder. Psychiatr Serv. 2003 Jan; 54(1):84-91.
    View in: PubMed
    Score: 0.008
  7. Racial differences in psychotic symptoms among combat veterans with PTSD. Depress Anxiety. 2002; 16(4):157-61.
    View in: PubMed
    Score: 0.008
  8. Absenteeism and productivity among mental health employees. Adm Policy Ment Health. 2001 Sep; 29(1):41-50.
    View in: PubMed
    Score: 0.008
  9. Psychotic features in chronic posttraumatic stress disorder and schizophrenia: comparative severity. J Nerv Ment Dis. 2000 Apr; 188(4):217-21.
    View in: PubMed
    Score: 0.007
  10. An overview of side effects caused by typical antipsychotics. J Clin Psychiatry. 2000; 61 Suppl 8:5-11; discussion 12-3.
    View in: PubMed
    Score: 0.007
  11. Differentiation of depression and PTSD symptoms in combat veterans. Depress Anxiety. 2000; 11(4):175-9.
    View in: PubMed
    Score: 0.007
  12. Alcohol dependence and hospitalization in schizophrenia. Schizophr Res. 1999 Jul 27; 38(1):71-5.
    View in: PubMed
    Score: 0.007
  13. Panic disorder in schizophrenia. Can J Psychiatry. 1999 Jun; 44(5):488-90.
    View in: PubMed
    Score: 0.006
  14. Psychotic features and illness severity in combat veterans with chronic posttraumatic stress disorder. Biol Psychiatry. 1999 Apr 01; 45(7):846-52.
    View in: PubMed
    Score: 0.006
  15. rTMS studies of mood and emotion. Electroencephalogr Clin Neurophysiol Suppl. 1999; 51:304-14.
    View in: PubMed
    Score: 0.006
  16. Serotonin reuptake antidepressant effects on sexual function in patients with anxiety disorders. Biol Psychiatry. 1998 Jun 15; 43(12):904-7.
    View in: PubMed
    Score: 0.006
  17. Why the triple-threat approach threatens the viability of academic medical centers. Acad Med. 1998 Feb; 73(2):123-5.
    View in: PubMed
    Score: 0.006
  18. Sexual dysfunction induced by serotonin reuptake antidepressants. J Sex Marital Ther. 1998 Jan-Mar; 24(1):3-12.
    View in: PubMed
    Score: 0.006
  19. Dexamethasone for treatment of major depression in patients with bipolar disorder. Am J Psychiatry. 1995 Jun; 152(6):959-60.
    View in: PubMed
    Score: 0.005
  20. Dexamethasone for the treatment of depression: a randomized, placebo-controlled, double-blind trial. Am J Psychiatry. 1995 Feb; 152(2):265-7.
    View in: PubMed
    Score: 0.005
  21. Oral contraceptives and panic disorder. J Clin Psychiatry. 1992 May; 53(5):163-5.
    View in: PubMed
    Score: 0.004
  22. Intravenous dexamethasone for symptoms of major depressive disorder. Am J Psychiatry. 1991 Oct; 148(10):1401-2.
    View in: PubMed
    Score: 0.004
  23. Dexamethasone for the treatment of depression: a preliminary report. J Clin Psychiatry. 1991 Jul; 52(7):304-6.
    View in: PubMed
    Score: 0.004
  24. Inpatient management of violent behavior: nursing prevention and intervention. Issues Ment Health Nurs. 1991 Jun-Sep; 12(3):239-52.
    View in: PubMed
    Score: 0.004
  25. Dexamethasone suppression test in the diagnosis of depression. JAMA. 1991 May 01; 265(17):2253-4.
    View in: PubMed
    Score: 0.004
  26. Substance abuse in an inpatient psychiatric sample. Am J Drug Alcohol Abuse. 1991; 17(4):389-97.
    View in: PubMed
    Score: 0.004
  27. The effect of diagnostic methodology on the sensitivity of the TRH stimulation test for depression: a literature review. Biol Psychiatry. 1990 Oct 15; 28(8):733-7.
    View in: PubMed
    Score: 0.004
  28. Metaclopramide neurotoxicity. J S C Med Assoc. 1988 Nov; 84(11):542-5.
    View in: PubMed
    Score: 0.003
  29. Carbamazepine-induced reduction of plasma alprazolam concentrations: a clinical case report. J Clin Psychiatry. 1988 Nov; 49(11):448-9.
    View in: PubMed
    Score: 0.003
  30. Efficacy of anticholinergic prophylaxis for neuroleptic-induced acute dystonia. Am J Psychiatry. 1988 Aug; 145(8):993-6.
    View in: PubMed
    Score: 0.003
  31. The dexamethasone suppression index: enhancement of DST diagnostic utility for depression by expressing serum cortisol as a function of serum dexamethasone. Am J Psychiatry. 1988 Jun; 145(6):707-11.
    View in: PubMed
    Score: 0.003
  32. The dexamethasone suppression test and depression. Approaches to the use of a laboratory test in psychiatry. Endocrinol Metab Clin North Am. 1988 Mar; 17(1):21-39.
    View in: PubMed
    Score: 0.003
  33. The dexamethasone suppression test and depression. Approaches to the use of a laboratory test in psychiatry. Neurol Clin. 1988 Feb; 6(1):21-39.
    View in: PubMed
    Score: 0.003
  34. Does carbamazepine-induced reduction of plasma haloperidol levels worsen psychotic symptoms? Am J Psychiatry. 1986 May; 143(5):650-1.
    View in: PubMed
    Score: 0.003
  35. Improving oversight of the graduate medical education enterprise: one institution's strategies and tools. Acad Med. 2006 May; 81(5):419-25.
    View in: PubMed
    Score: 0.003
  36. The use of benzodiazepines for psychotic disorders: a literature review and preliminary clinical findings. Psychopharmacol Bull. 1986; 22(1):77-87.
    View in: PubMed
    Score: 0.003
  37. The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review. Arch Gen Psychiatry. 1985 Dec; 42(12):1193-204.
    View in: PubMed
    Score: 0.003
  38. Alprazolam-induced mania: two clinical cases. Am J Psychiatry. 1985 Mar; 142(3):368-9.
    View in: PubMed
    Score: 0.002
  39. Trazodone-induced mania following desipramine-induced mania in major depressive disorders. Am J Psychiatry. 1985 Mar; 142(3):386.
    View in: PubMed
    Score: 0.002
  40. Does the dexamethasone suppression test have clinical utility in psychiatry? J Clin Psychiatry. 1985 Feb; 46(2 Pt 2):25-9.
    View in: PubMed
    Score: 0.002
  41. Plasma corticosterone and cortisol following dexamethasone in psychiatric patients. Psychoneuroendocrinology. 1985; 10(1):49-60.
    View in: PubMed
    Score: 0.002
  42. Neural correlates of speech anticipatory anxiety in generalized social phobia. Neuroreport. 2004 Dec 22; 15(18):2701-5.
    View in: PubMed
    Score: 0.002
  43. Association between low plasma levels of dexamethasone and elevated levels of cortisol in psychiatric patients given dexamethasone. Am J Psychiatry. 1984 Dec; 141(12):1619-20.
    View in: PubMed
    Score: 0.002
  44. The dexamethasone suppression test in psychotic disorders. Am J Psychiatry. 1983 Nov; 140(11):1521-3.
    View in: PubMed
    Score: 0.002
  45. The predictive power of diagnostic tests and the effect of prevalence of illness. Arch Gen Psychiatry. 1983 May; 40(5):569-73.
    View in: PubMed
    Score: 0.002
  46. Dexamethasone suppression test. J Clin Psychiatry. 1983 Mar; 44(3):116-7.
    View in: PubMed
    Score: 0.002
  47. The impaired physician: a medical and social dilemma. Gen Hosp Psychiatry. 1982 Jul; 4(2):147-54.
    View in: PubMed
    Score: 0.002
  48. Implementation of a college-wide GME core curriculum. Acad Med. 2001 Apr; 76(4):331-6.
    View in: PubMed
    Score: 0.002
  49. Brain effects of TMS delivered over prefrontal cortex in depressed adults: role of stimulation frequency and coil-cortex distance. J Neuropsychiatry Clin Neurosci. 2001; 13(4):459-70.
    View in: PubMed
    Score: 0.002
  50. A controlled trial of daily left prefrontal cortex TMS for treating depression. Biol Psychiatry. 2000 Nov 15; 48(10):962-70.
    View in: PubMed
    Score: 0.002
  51. Repetitive transcranial magnetic stimulation: perspectives for application in the treatment of bipolar and unipolar disorders. Bipolar Disord. 1999 Dec; 1(2):73-80.
    View in: PubMed
    Score: 0.002
  52. Research on field-based services: models for reform in the delivery of mental health care to populations with complex clinical problems. Am J Psychiatry. 1995 Aug; 152(8):1111-23.
    View in: PubMed
    Score: 0.001
  53. The effect of benztropine on haloperidol-induced dystonia, clinical efficacy and pharmacokinetics: a prospective, double-blind trial. J Clin Psychopharmacol. 1991 Apr; 11(2):106-12.
    View in: PubMed
    Score: 0.001
  54. Toxicity resulting from lithium augmentation of antidepressant treatment in elderly patients. J Clin Psychiatry. 1990 Aug; 51(8):344-5.
    View in: PubMed
    Score: 0.001
  55. Rapid response of patients simultaneously treated with lithium and nortriptyline. J Clin Psychiatry. 1990 Mar; 51(3):124-5.
    View in: PubMed
    Score: 0.001
  56. Refractory rapid cycling unipolar depression responds to lithium and carbamazepine treatment. J Clin Psychiatry. 1989 Sep; 50(9):356-7.
    View in: PubMed
    Score: 0.001
  57. The DST in children and adolescents with major depressive disorder. Am J Psychiatry. 1989 Apr; 146(4):503-7.
    View in: PubMed
    Score: 0.001
  58. Effect of tobacco withdrawal on the dexamethasone suppression test. Biol Psychiatry. 1988 Jan 01; 23(1):96-8.
    View in: PubMed
    Score: 0.001
  59. Methylene blue: a reliable and practical marker for validating compliance on the DST. J Clin Psychiatry. 1987 Jun; 48(6):224-9.
    View in: PubMed
    Score: 0.001
  60. Heterogeneity in anorexia nervosa. Biol Psychiatry. 1986 Feb; 21(2):213-6.
    View in: PubMed
    Score: 0.001
  61. A clinical report of thymoleptic-responsive atypical paranoid psychoses. Am J Psychiatry. 1983 Sep; 140(9):1187-90.
    View in: PubMed
    Score: 0.001
  62. Aporphines. 48. Enantioselectivity of (R)-(-)- and (S)-(+)-N-n-propylnorapomorphine on dopamine receptors. J Med Chem. 1983 Apr; 26(4):516-21.
    View in: PubMed
    Score: 0.001
  63. Comparison of solid-phase radioimmunoassay and competitive protein binding method for postdexamethasone cortisol levels in psychiatric patients. Psychiatry Res. 1983 Mar; 8(3):199-206.
    View in: PubMed
    Score: 0.001
  64. Mood, vegetative disturbance, and dexamethasone suppression test after stroke. Ann Neurol. 1982 Nov; 12(5):463-8.
    View in: PubMed
    Score: 0.001
  65. An orally effective, long-acting dopaminergic prodrug: (-)-10,11-methylenedioxy-N-propylnoraporphine. Eur J Pharmacol. 1982 Jan 08; 77(1):87-8.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.